Michael Fossel
Professor and author of several books on aging
Author of a major book on Telomerase Therapy, which the Wall Street Journal named as one of the five best science books of the year, and working to bring telomerase therapy to human trials, Michael Fossel, M.D., Ph.D. (born 1950, Greenwich, Connecticut) was a professor of clinical medicine at Michigan State University for almost 30 years and still teaches Biology of Aging as a university professor.
Founder and former editor-in-chief of Rejuvenation Research, he is best known for his views on telomerase therapy as a possible treatment for cellular senescence and human age-related disease. Dr. Fossel has appeared on many major news programs to discuss aging and regularly on National Public Radio (NPR). He is also a respected lecturer, author, and physician.Prior to earning his M.D. at Stanford Medical School, Fossel earned a joint B.A. (cum laude) and M.A. in psychology at Wesleyan University and a Ph.D. in neurobiology at Stanford University. He is also a graduate of Phillips Exeter Academy. After graduating from medical school in 1981, he was awarded a National Science Foundation fellowship and taught at Stanford University Medical School.
Visit website: http://www.michaelfossel.com/
See also: 
Telocyte
- Company focused on the development of telomerase therapy to treat Alzheimer's disease.
Details last updated 18-Oct-2019
Michael Fossel is also referenced in the following:
Age-Related Disease Therapeutics Summit
31-May-2023 to 02-Jun-2023
Event about aging and aging related diseases organized by Hanson Wade
Global Longevity Federation (GLF 2023)
15-May-2023 to 16-May-2023
The conference by Sciinov Group tries to put together an exciting scientific programme focused on longevity
Michael Fossel Creations
The Telomerase Revolution
Book written by Michael Fossel speaks about the Enzyme That Holds the Key to Human Aging and Will Lead to Longer, Healthier Lives
Michael Fossel News
Reason reports back from Age-Related Disease Therapeutics Summit 2023
Fight Aging! - 16-Jun-2023
Many people believe lots of clinical trials of novel therapeutics targeting mechanisms of aging will start up in the next few years
Read more...Telocyte secures new investment, taking telomerase gene therapy to the clinic in CVD and more
Longevity Technology - 03-Feb-2023
The researchers will not only focus on CVD or cellular aging but the optimal point of intervention
Read more...Dr. Michael Fossel interviewed by LEAF
Lifespan.io (LEAF) - 18-Nov-2019
Fossel argues for telomerase therapy over senolytics
Read more...Our Complicated Relationship to Longevity
LARB - 04-Oct-2016
Book review: Cracking the Aging Code by Josh Mitteldorf, Dorion Sagan Extending life is not just...
Read more...Telomere Length and Mortality
Humanity+ - 04-May-2015
Danish study of 65,000 people shows telomere length robustly predicts longevity. The study was p...
Read more...
